Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review

The implantable cardioverter-defibrillator (ICD) may be associated with a high risk of complications in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). However, ICDs in this population have not been systematically evaluated.

Source: Heart Rhythm - July 3, 2018 Category: Cardiology Authors: Thomas M. Roston, Karolina Jones, Nathaniel M. Hawkins, J. Martijn Bos, Peter J. Schwartz, Frances Perry, XX, Michael J. Ackerman, Zachary W.M. Laksman, Padma Kaul, Krystien V.V. Lieve, Joseph Atallah, Andrew D. Krahn, Shubhayan Sanatani Source Type: research